Oct 9, 2025 4:05 pm EDT VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants
Aug 14, 2025 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update
Aug 8, 2025 8:30 am EDT VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update
Jul 8, 2025 8:00 am EDT Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
Jun 12, 2025 8:30 am EDT Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
